Instituto De Retina Genomica

03/11/2025

Retinosis pigmentaria cura, otro gene modificador para varios genes ( gene-agnóstico). https://sparingvision.com/sparingvision-doses-first-patient-with-spvn20-for-advanced-retinitis-pigmentosa-in-nyrvana-trial/🥳

Favorable safety profile of SPVN06 observed in Phase I including nine patients with severe advanced retinitis pigmentosa. Trial advances into Phase II extension phase, with two highest doses of SPVN06, following DSMB positive recommendation

03/11/2025

Avanzando en Stargardts. ¡ Contáctenos !

02/11/2025

Retinosis pigmentaria cura - otro promotor para varios genes. ¡ Contáctenos !

29/10/2025

Mejoran 15 líneas pacientes con Retinosis, Stargardts y degeneración macular.

Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology....

20/10/2025

Microchip instalado en pacientes con Degeneacion mácula. Recobran visión.

The results are astounding and a major advance, say surgeons involved in international research using the pioneering technology.

03/10/2025

Paciente con distrofia de retina tipo Stargardt´s ABCA4 rumbo al tratamiento. 🥳

13/08/2025

Primer tratamiento para distrofia de conos> bastones ABCA4, conocido como Stargardt’s.

29/07/2025

Primer paciente Stargardt’a conos> bastones ( ABCA4) inyectado: seguridad y eficacia mostrados.

Ocugen, Inc. Announces First Patient Dosed in Phase 2/3 GARDian3 Pivotal Confirmatory Trial for OCU410ST—Novel Modifier Gene Therapy Candidate for Stargardt Disease

08/06/2025

Terapia genica NR2E3- promotor, para casi todos los tipos mutacionales.
MejoraVisionMD.com

08/06/2025

Avances para gene ABCA4

VG801 is a dual AAV gene therapy that leverages mRNA trans-splicing via the vgRNA REVeRT and vgAAV platforms to deliver the full-length ABCA4 gene for Stargardt disease and related retinal disorders.

16/05/2025

Tratamientos genicos, ahora casi todos los genes. ¿Cuál es su tipo mutacional?